CORDIS · 101160259 · HORIZON

ZeNCure ENHANCING NON-COMMUNICABLE DISEASE RESEARCH EXCELLENCE THROUGH ZEBRAFISH CAPACITY BUILDING

Coordinator: INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS)

ZeNCure aims to foster collaborative research and enhance scientific excellence at the Institute of Molecular Genetics and Genetic Engineering, University of Belgrade (IMGGE) in Serbia. This ambitious initiative brings together IMGGE with world-renowned research institutions in Germany (MPG), Portugal (CF) and the United Kingdom (UoS) along with an associated partner from Latvia (BGI RFL). The overarching goal is to elevate IMGGE's research profile by strengthening its capabilities in zebrafish (ZF) research, particularly in the context of non-communicable diseases (NCDs). NCDs pose a signifi…

EU contribution
€1.3M
Total cost
€0
Period
2024-10-01 → 2027-09-30
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-CSA
Call
HORIZON-WIDERA-2023-ACCESS-02
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

0 EU contribution: €1.3M awarded to the consortium. The project runs over approximately 3 years from 2024-10-01 to 2027-09-30.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
What is the EU contribution?
The European Commission contributes €1.3M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2023-ACCESS-02.
Who coordinates the project?
The project is coordinated by INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS).
What is the project timeline?
The project runs from 2024-10-01 to 2027-09-30 — approximately 3 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101160259.